Assessment of changes to screening programmes: why randomisation is important

Field	Value	Language
dc.contributor.author	Bell, Katy J.L.
dc.contributor.author	Bossuyt, Patrick
dc.contributor.author	Glasziou, Paul
dc.contributor.author	Irwig, Les
dc.date.accessioned	2021-04-29T04:33:26Z
dc.date.available	2021-04-29T04:33:26Z
dc.date.issued	2015	en
dc.identifier.uri	https://hdl.handle.net/2123/24999
dc.description.abstract	Screening programmes sometimes need to be adapted as new technologies and treatments become available. Katy Bell and colleagues argue the best way to assess such changes is through randomised trials within the programmes	en
dc.language.iso	en	en
dc.publisher	BMJ Publishing Group	en
dc.relation.ispartof	British Medical Journal	en
dc.rights	Copyright All Rights Reserved	en
dc.subject	epidemiology	en
dc.subject	screening	en
dc.subject	diagnostic test	en
dc.subject	oncology	en
dc.title	Assessment of changes to screening programmes: why randomisation is important	en
dc.type	Article	en
dc.subject.asrc	1117 Public Health and Health Services	en
dc.identifier.doi	10.1136/bmj.h1566
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Health	en
usyd.citation.volume	350	en
usyd.citation.spage	h1566	en
workflow.metadata.only	Yes	en

Associated file/s

There are no files associated with this item.